Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 03 - 01 symbols : Snynf save search
Insights on the Travel Vaccines Global Market to 2027 - by Composition, Disease and Region
Published: 2022-03-01 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.09%
H: 0.05%
C: 0.05%
AZNCF | $138.24 -4.19% 800
|
Health Technology
|
| O: 0.37%
H: 2.02%
C: 2.02%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.39%
H: 0.0%
C: 0.0%
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 5.88%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.55%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.64%
H: 0.0%
C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -1.34%
H: 2.05%
C: 1.47%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.96%
H: 0.0%
C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.62%
H: 0.0%
C: 0.0%
ALT | $6.91 0.29% 0.29% 3.6M
|
Commercial Services
|
| O: 2.74%
H: 1.34%
C: -2.14%
travel disease vaccine
New Activia+ Multi-Benefit Drinkable Yogurt with Added Nutrients Helps Support Your Immune System
Published: 2022-03-01 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -3.33%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.3%
H: 0.0%
C: 0.0%
system
Biopharma Takes a Decisive Position on the Russia-Ukraine Conflict
Published: 2022-03-01 (Crawled : 17:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -3.33%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.3%
H: 0.0%
C: 0.0%
biopharma russia positive
Alnylam Announces U.S. Food and Drug Administration Acceptance of Supplemental New Drug Application for OXLUMO® for the Treatment of Advanced Primary Hyperoxaluria Type 1
Published: 2022-03-01 (Crawled : 16:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -3.33%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.3%
H: 0.0%
C: 0.0%
ALNY | News | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 0.65%
H: 3.47%
C: 2.28%
oxlumo new drug treatment application drug food
Sanofi and Regeneron's Dupixent Poised to Keep Shining in 2022
Published: 2022-03-01 (Crawled : 16:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -3.33%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.3%
H: 0.0%
C: 0.0%
dupixent
Mereo BioPharma Announces Appointment of Anne Hyland to Board of Directors
Published: 2022-03-01 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -3.33%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.3%
H: 0.0%
C: 0.0%
MREO | $2.64 -0.38% -0.38% 910K
|
Health Technology
|
| O: -2.42%
H: 6.61%
C: 1.65%
biopharma ces
DarioHealth Enters into Strategic Agreement with Sanofi U.S.
Published: 2022-03-01 (Crawled : 12:30) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -3.33%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.3%
H: 0.0%
C: 0.0%
DRIO | $1.17 1.74% 1.71% 50K
|
Health Technology
|
| O: 9.38%
H: 1.26%
C: -3.4%
health
Long term study confirms efficacy of ISA Pharmaceuticals' T-cell activating immunotherapy in combination with checkpoint inhibitor
Published: 2022-03-01 (Crawled : 09:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -3.33%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.3%
H: 0.0%
C: 0.0%
als long term cel immunotherapy therapy t-cell
Botanical and Plant-Derived Drugs Market to Grow by USD 15.89 bn | Technavio
Published: 2022-03-01 (Crawled : 05:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.75%
H: 0.0%
C: -7.0%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -3.33%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.9%
H: 0.0%
C: -1.59%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.3%
H: 0.0%
C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.05%
H: 0.81%
C: -0.91%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.3%
H: 0.0%
C: 0.0%
JAZZ | $109.96 0.63% 0.63% 760K
|
Health Technology
|
| O: -1.14%
H: 1.11%
C: 0.51%
drug
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.